Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:48 PM
Ignite Modification Date:
2025-12-24 @ 5:48 PM
NCT ID:
NCT05127668
Eligibility Criteria:
Inclusion Criteria:
* Participants \> 18 years old
* Able to give written informed consent
* Able to understand and complete questionnaire forms independently
Exclusion Criteria:
* Participants \< 18 years old
* Participants with cancer and/or undergoing chemotherapy
* Participants with difficult to cannulate veins (DTCV)
* Participants with lymphoedema in either hand
* Participants with pre-existing Raynaud's disease
* Participants with Diabetes (Type 1 \& 2)
* Participants with generalised anxiety disorder
* Participants with diagnosis of hypertension
* Participants with any cardiovascular disease, previous stroke, episodes of DVT, recent treatment for venous thromboembolism (VTE), recently administered heparin, participants on warfarin or any anticoagulant treatment (including NOACs).
* Participants not able to give written informed consent
* Participants not able to comprehend or complete questionnaire forms independently
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05127668
Study Brief:
Protocol Section:
NCT05127668